Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors [Phase 1]
Phase 1 study assessing the safety and feasibility of combining propranolol (Hemangiol) with oral metronomic vinorelbine (Navelbine) in chil…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors [Phase 4]
Phase 4 clinical trial update evaluating the effects of age and kidney function on the safety, efficacy, and pharmacokinetics of OctreoScan …
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Oral Bioavailability and Mass Balance Trial With Pimasertib [Phase 1]
Phase 1 trial evaluating oral bioavailability and mass balance of pimasertib in patients with locally advanced or metastatic solid tumors; r…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine [Phase 1]
Phase Ib trial assessing safety, tolerability, and preliminary efficacy of LY2780301 in combination with gemcitabine in solid tumors and non…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma) [Phase 1]
A Phase 1 clinical trial of ASP3026 in patients with advanced malignancies, including solid tumors and B-cell lymphoma, has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy [Phase 4]
A Phase 4 clinical trial evaluating PEG-rhG-CSF in patients with malignant solid tumors undergoing chemotherapy has been completed.
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1) [Phase 1]
Phase 1 trial evaluating dalotuzumab alone and in combination with ridaforolimus in pediatric patients with advanced solid tumors has comple…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial update of aflibercept (VEGF Trap) in patients with relapsed or refractory solid tumors or Non-Hodgkin's lymphoma; the study ha…
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 cardiac safety study of evofosfamide (TH-302) in patients with advanced solid tumors; the current status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer [Phase 1]
Phase 1 trial update evaluating safety and pharmacokinetics interactions between olaparib and endocrine therapies (anastrozole, letrozole, t…
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: An Open Label Dose Escalation Study Of E7080 [Phase 1]
Open-label Phase 1 dose-escalation trial of E7080 (lenvatinib) in solid tumors and lymphomas completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650) [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of MK-8242 in participants with advanced solid tumors; trial terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors [Phase 1]
Completed Phase 1 multicenter dose-escalation study evaluating the combination of pazopanib and bevacizumab in patients with metastatic rena…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function [Phase 1]
Open-label Phase 1 study evaluating pharmacokinetics and safety of HALAVEN (eribulin mesylate) in adults with cancer and impaired renal func…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours [Phase 1]
The document reports the completion of a Phase 1 safety study of the investigational drug SLC-0111 in subjects with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain [Phase 3]
Phase 3 trial comparing morphine to methadone as first-line opioids for cancer pain was terminated, with results posted in May 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction [Phase 1]
Phase 1 pharmacokinetic study of oral ixazomib in cancer patients with liver dysfunction to assess exposure and safety.
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours [Phase 1]
Phase I, open-label, single-arm dose-escalation study of dichloroacetate in patients with recurrent and/or metastatic solid tumors; the tria…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies [Phase 2]
Phase 2 trial of Brentuximab Vedotin in CD30-positive non-lymphomatous malignancies has completed and results were posted in 2016. The study…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma [Phase 1]
This report summarizes the completed Phase 1 dose-escalation safety study of TL32711 in adults with refractory solid tumors or lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors [Phase 1]
A Phase 1 study evaluating continuous intravenous infusion of Terameprocol (EM-1421) in patients with refractory solid tumors and lymphoma w…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating repeated infusion of CELYVIR in children and adults with metastatic and refractory solid tum…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients [Phase 1]
Phase I dose-escalation study of SAR125844 in Asian patients with solid tumors has been completed.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) [Phase 1]
Phase 1 trial of robatumumab (SCH 717454, MK-7454) in combination with different regimens in pediatric participants with advanced solid tumo…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours [Phase 2]
This Phase 2 trial update notes the completion of studies evaluating temozolomide in combination with topotecan for refractory and relapsed …